Deal notes
The $2,266,112 figure is available ATM offering capacity under the disclosed public-float limit, not cash raised. Shares may be sold over time; actual sales, proceeds and a fixed offering price are not established by these filings.
Original source ↗Transaction overview
01Amesite Inc. disclosed an at-the-market program event: facility established. Available capacity is $2.3M. This event does not record cash proceeds raised.
- Financing type
- ATM
- Announcement date
- —
- SEC disclosure date
- Jul 17, 2026
- Agreement date
- Jul 17, 2026
- Pricing date
- —
- Closing date
- —
- Filing date
- Jul 20, 2026
- Status
- Announced
- Market cap before SEC disclosure
- $4.8M
- Prior closing price
- $1.05
- Raise as % of market cap
- —
Market data · FMP
- Historical market cap
- $4,847,629.5
- Market date
- Jul 16, 2026
- Closing price
- $1.05
- Latest reported shares outstanding
- 6,549,850
- Latest reported float shares
- 5,949,853
- Share-data date
- Oct 7, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 8, 2026.
Financial Modeling Prep ↗Financing terms
02At-the-market program
- Capital event
- Facility established
- Available capacity
- $2.3M
- Proceeds raised
- Not reported as raised
- Shares sold
- —
- Average sale price
- —
- Relevant period
- Not applicable
- Sales commission
- 3%
Security structure
- Price / security basis
- Common shares
- Units offered
- —
- Preferred class
- Not applicable
- Preferred shares offered
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- 3%
- Agent fee amount
- —
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
Filing evidence & original calculations
Facility established
On July 17, 2026, Amesite Inc. (the “Company”), entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC as agent (the “Agent”), pursuant to which the Company may offer and sell, from time to time through the Agent, shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to the Maximum Amount (as defined in the ATM Agreement).Original source ↗
Common shares
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
ATM
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
Announced
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
sec_disclosure
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
2026-07-17
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
2026-07-17
On July 17, 2026, Amesite Inc. (the “Company”), entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC as agent (the “Agent”), pursuant to which the Company may offer and sell, from time to time through the Agent, shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to the Maximum Amount (as defined in the ATM Agreement).Original source ↗
Available capacity
Accordingly, based on the foregoing, we are currently eligible under General Instruction I.B.6 of Form S-3 to offer and sell shares of our common stock having an aggregate offering price of up to approximately $2,266,112.Original source ↗
2266112
We have entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”), relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,266,112 from time to time through the Sales Agent, acting as agent under the prospectus supplement and the accompanying prospectus.Original source ↗
3
We will pay Wainwright a cash commission of 3.0% of the gross sales price of the shares of our common stock that Wainwright sells pursuant to the Sales Agreement. Because there is no minimum offering amount required as a condition to this offering, the actual total offering amount, commissions and proceeds to us, if any, are not determinable at this time.Original source ↗
FMP reported market cap; as of 2026-07-16.
{"provider":"FMP","policy":"fmp-primary-v1","symbol":"AMST","marketCap":4847629.5,"closingPrice":1.05,"asOf":"2026-07-16","retrievedAt":"2026-10-08T17:43:33.779791+00:00","outstandingShares":6549850,"floatShares":5949853,"sharesAsOf":"2026-10-07","sharesBasis":"latest_provider_snapshot","marketCapSource":"https://site.financialmodelingprep.com/developer/docs","priceSource":"https://site.financialmodelingprep.com/developer/docs","sharesSource":"https://site.financialmodelingprep.com/developer/docs"}Original source ↗